D Albano, F Dondi, M Ravanelli, A Tucci… - … Myeloma and Leukemia, 2022 - Elsevier
Sarcopenia is considered to be a poor prognostic factor for several oncological diseases; however, some promising results for lymphoma are now available. The definition of …
Objectives: High-dose CT (HDCT) is considered the gold-standard imaging for the measurements of skeletal muscle area (SMA), visceral adipose tissue (VAT), subcutaneous …
G Besutti, F Massaro, E Bonelli, L Braglia… - Frontiers in …, 2021 - frontiersin.org
Baseline CT scans of 116 patients (48% female, median 64 years) with diffuse large B-cell lymphoma (DLBCL) were retrospectively reviewed to investigate the prognostic role of …
A Mishra, KD Bigam, M Extermann… - Journal of cachexia …, 2020 - Wiley Online Library
Background Quantification of skeletal muscle using computed tomography (CT) is accessible using cancer patients' standard oncologic images. Reduced muscle mass may …
D Albano, F Dondi, G Treglia, A Tucci, M Ravanelli… - Cancers, 2022 - mdpi.com
Simple Summary The effective role of sarcopenia and body changes during treatment in elderly (> 65 years) Hodgkin lymphoma (HL) is unclear. The aim of our study was to analyze …
M Jullien, B Tessoulin, H Ghesquières, L Oberic… - Cancers, 2021 - mdpi.com
Simple Summary Cachexia is a major cause of mortality in cancer patients and is characterized by a continuous skeletal muscle loss. Muscle depletion assessed by …
J Kirsten, V Wais, SVW Schulz, E Sala, G Treff… - Cancers, 2021 - mdpi.com
Simple Summary Allogenic stem cell transplantation is a treatment option for various hematological diseases. Due to the intensity of the therapy regimes used, there is a …
AZ Pereira, B de Almeida‐Pitito… - Journal of Parenteral …, 2021 - Wiley Online Library
Rationale: Many studies have shown the importance of body composition parameters, muscle, and fat mass, evaluated by several methods in hematopoietic stem cell …
A Lorenc, J Hamilton-Shield, R Perry… - Journal of Cancer …, 2020 - Springer
Purpose To collate evidence of changes in body composition following treatment of leukaemia in children, teenagers and young adults (CTYA, 0–24 years) with allogeneic …